Sickle Cell and Cannabis-2018 Aug

Sickle Cell and Cannabis-2018 Aug

In 2018, survey data published in the journal Cannabis and Cannabinoid Research  shows Medical cannabis use is relatively common among patients with sickle cell disease for pain control. Background: surveyed patients with a brief, anonymous, questionare. Reviewed institutional records for clinically driven urine drug testing. While we tracked patient requests for certification for medical marijuana. You can Read .. Read More

MS, Marijuana, Pain and Spasticity Study -2018 Jul

In 2018, After a review of scientific studies, researchers say extracts from marijuana plants can help treat pain and spasticity symptoms in people with multiple sclerosis. Background: looked at the safety and effectiveness of cannabis as well as studying its impact on disability and disability progression, pain, spasticity, bladder function, tremor/ataxia, quality of life, and .. Read More

Neuropathic Pain & Cannibinoids-2009 Oct

In 2009, Cannabinoids as pharmacotherapies for neuropathic pain: nerve injury, diabetes, chemotherapeutic treatment, human immunodeficiency virus, multiple sclerosis, and herpes zoster infection is considered. Background: review of clinical and preclinical literature evaluating CB1, CB2, THC You can read the full article here =>

Pain Management Study for Elderly-2018 Mar

In 2018, Studied the safety and efficacy of medical cannabis in elderly treatments of 2736 patients.  Background: A prospective study that included all patients above 65 years of age who received medical cannabis from January 2015 to October 2017. You can read the full article here =>

Chronic Pain Study Spinal Cord Injury-2006

In 2016, A Survey Study of Treatments for Chronic Pain in Persons With Spinal Cord Injury. BACKGROUND: To determine the degree and duration of pain relief provided by specific pain treatments used by individuals with spinal cord injury (SCI) who have chronic pain. You can read the full article here =>

Fibromyalgia Findings-2014 Apr

In 2014, Survive shows Marijuana rated most effective for treating Fibromyalgia. BACKGROUND: Many who responded to the survey said they had tried all three FDA approved drugs.With none rated higher than 10% effective. You can read the full article here =>

Fibromyalgia Research-2016 Jul

in 2016, Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes BACKGROUND: The commonality in symptomatology in these conditions displaying hyperalgesia and central sensitization with possible common underlying pathophysiology suggests that a clinical endocannabinoid deficiency might characterize their origin. You can read the full article here .. Read More